| . "Development and validation of a natural language processing tool to generate the CONSORT reporting checklist for randomized clinical trials.." JAMA Netw Open. 2020;3(10):e2014661. Pub Med |
| . "Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring.." Lifetime Data Anal. 2011;17(4):566-93. Pub Med |
| . "Estimation of treatment effects and model diagnostics with two-way time-varying treatment switching: an application to a head and neck study.." Lifetime Data Anal. 2020;26(4):685-707. Pub Med |
| . "Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer.." Lung Cancer. 2020;141():14-20. Pub Med |
| . "A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events.." Pharm Stat. 2015;14(4):273-83. Pub Med |
| . "On model selections for repeated measurement data in clinical studies.." Stat Med. 2015;34(10):1621-33. Pub Med |
| . "Estimation of treatment effect for the sequential parallel design.." Stat Med. 2011;30(30):3496-506. Pub Med |
| . "Meta-analysis methods and models with applications in evaluation of cholesterol-lowering drugs.." Stat Med. 2012;31(28):3597-616. Pub Med |
| . "Auxiliary variable-enriched biomarker-stratified design.." Stat Med. 2018;37(30):4610-4635. Pub Med |
| . "Sample size estimation in educational intervention trials with subgroup heterogeneity in only one arm.." Stat Med. 2013;32(12):2140-54. Pub Med |
| . "Assessing temporal agreement between central and local progression-free survival times.." Stat Med. 2015;34(5):844-58. Pub Med |
| . "Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials.." Stat Med. 2014;33(27):4715-33. Pub Med |
| . "Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.." Stat Med. 2017;36(3):403-415. Pub Med |
| . "Sample size calculation for cluster randomization trials with a time-to-event endpoint.." Stat Med. 2020;39(25):3608-3623. Pub Med |
| . "A multiple imputation strategy for sequential multiple assignment randomized trials.." Stat Med. 2014;33(24):4202-14. Pub Med |
| . "Pattern mixture models for clinical validation of biomarkers in the presence of missing data.." Stat Med. 2017;36(19):2994-3004. Pub Med |
| . "Bayesian modeling and inference for clinical trials with partial retrieved data following dropout.." Stat Med. 2013;32(24):4180-95. Pub Med |
| . "Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.." Stat Med. 2016;35(8):1245-56. Pub Med |
| . "Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials.." Stat Med. 2012;31(29):3789-804. Pub Med |
| . "A model-based conditional power assessment for decision making in randomized controlled trial studies. ." Stat Med. 2017;36(30):4765-4776. Pub Med |
| . "A new Bayesian joint model for longitudinal count data with many zeros, intermittent missingness, and dropout with applications to HIV prevention trials.." Stat Med. 2019;38(30):5565-5586. Pub Med |
| . "Dynamic treatment regimes, past, present, and future: A conversation with experts.." Stat Methods Med Res. 2017;26(4):1605-1610. Pub Med |
| . "Meta-analysis for discovering rare-variant associations: Statistical methods and software programs.." Am J Hum Genet. 2015;97(1):35-53. Pub Med |
| . "A general framework for detecting disease associations with rare variants in sequencing studies.." Am J Hum Genet. 2011;89(3):354-67. Pub Med |
| . "Sample size/power calculation for stratified case-cohort design.." Stat Med. 2014;33(23):3973-85. Pub Med |
| . "Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.." J Pharmacol Exp Ther. 2013;347(3):599-606. Pub Med |
| . "Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.." J Pharmacol Exp Ther. 2013;347(3):599-606. Pub Med |
| . "Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.." J Pharmacol Exp Ther. 2013;347(3):599-606. Pub Med |
| . "A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.." Clin Cancer Res. 2012;18(18):5099-109. Pub Med |
| . "Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR(+), HER2(-) breast cancer that had progressed during or after prior endocrine therapy.." Breast Cancer Res. 2017;19(1):18. Pub Med |
| . "Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer.." Breast Cancer Res Treat. 2017;166(1):167-177. Pub Med |
| . "Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma.." Cancer Discov. 2017;7(10):1116-1135. Pub Med |
| . "Translational Breast Cancer Research Consortium (TBCRC) 022: A phase II trial of Neratinib for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases.." J Clin Oncol. 2016;34(9):945-52. Pub Med |
| . "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med |
| . "Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma.." Cancer Discov. 2017;7(10):1116-1135. Pub Med |
| . "Impact of sex and gonadal steroids on neonatal brain structure.." Cereb Cortex. 2014;24(10):2721-31. Pub Med |
| . "Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR(+), HER2(-) breast cancer that had progressed during or after prior endocrine therapy.." Breast Cancer Res. 2017;19(1):18. Pub Med |
| . "Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer.." Breast Cancer Res Treat. 2017;166(1):167-177. Pub Med |
| . "Analysing breast cancer microarrays from African Americans using shrinkage-based discriminant analysis.." Hum Genomics. 2010;5(1):5-16. Pub Med |
| . "Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: Exploratory analysis of the REMAGUS02 trial.." J Clin Oncol. 2019;37(8):624-635. Pub Med |
| . "Meta-analysis of gene-level associations for rare variants based on single-variant statistics.." Am J Hum Genet. 2013;93(2):236-48. Pub Med |
| . "A general framework for studying genetic effects and gene-environment interactions with missing data.." Biostatistics. 2010;11(4):583-98. Pub Med |
| . "Meta-analysis of gene-level associations for rare variants based on single-variant statistics.." Am J Hum Genet. 2013;93(2):236-48. Pub Med |
| . "Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR(+), HER2(-) breast cancer that had progressed during or after prior endocrine therapy.." Breast Cancer Res. 2017;19(1):18. Pub Med |
| . "Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer.." Breast Cancer Res Treat. 2017;166(1):167-177. Pub Med |
| . "Increase in speech recognition due to linguistic mismatch between target and masker speech: monolingual and simultaneous bilingual performance.." J Speech Lang Hear Res. 2014;57(3):1089-97. Pub Med |
| . "Randomized, double-blind study comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer.." Future Oncol. 2016;12(11):1359-67. Pub Med |
| . "A comparison of proposed biosimilar LA-EP2006 and reference Pegfilgrastim for the prevention of neutropenia in patients with early-stage breast cancer receiving Myelosuppressive adjuvant or Neoadjuvant chemotherapy: Pegfilgrastim Randomized Oncology (Supp." Oncologist. 2016;21(7):789-94. Pub Med |
| . "Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.." Biometrics. 2014;70(4):1003-13. Pub Med |
| . "Semiparametric regression for the weighted composite endpoint of recurrent and terminal events.." Biostatistics. 2016;17(2):390-403. Pub Med |
